Cleared Traditional

K941144 - EXCEL EMG

K941144 is the FDA 510(k) clearance for EXCEL EMG by Excel Tech. , Ltd.. It is a Class 2 Neurology device (product code IKN) cleared through the Traditional 510(k) pathway after a 607-day FDA review.

K941144 · Excel Tech. , Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1995
Decision
607d
Days
Class 2
Risk

K941144 is an FDA 510(k) clearance for the EXCEL EMG. Classified as Electromyograph, Diagnostic (product code IKN), Class II - Special Controls.

Submitted by Excel Tech. , Ltd. (Oakville,Ontario, CA). The FDA issued a Cleared decision on November 7, 1995 after a review of 607 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 890.1375 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Excel Tech. , Ltd. devices

Submission Details

510(k) Number K941144 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 1994
Decision Date November 07, 1995
Days to Decision 607 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
459d slower than avg
Panel avg: 148d · This submission: 607d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IKN Electromyograph, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.1375
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - IKN Electromyograph, Diagnostic

All 12
Devices cleared under the same product code (IKN) and FDA review panel - the closest regulatory comparables to K941144.
XLTEK XCALIBUR EMG / LT, MODEL PK1P33, PK1059
K052112 · Excel Tech. , Ltd. · Oct 2005
NIM-PRS
K024316 · Medtronic Xomed, Inc. · Jan 2003
NEUROPACK MICRO, MODEL MED-9100A SERIES
K010590 · Nihon Kohden America, Inc. · Jun 2001
NAVIGATOR & TRAVELER EVOKED POSTENTIAL PRODUCT
K930328 · Bio-Logic Systems Corp. · Jul 1993
PHASIS ELECTROMYOGRAPH
K922488 · Biosound, Inc. · Mar 1993
EMG NAVIGATOR & EMG TRAVELER
K893130 · Bio-Logic Systems Corp. · Mar 1990